IONS
IONS
US4622221004
Ionis Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 943.711.000 705.138.000
33.8%
Cost of Revenue 15.909.000 11.215.000
41.9%
Gross Profit 927.802.000 693.923.000
33.7%
1.309.519.000 1.169.030.000
12.0%
Operating Income -381.717.000 -475.107.000
19.7%
Pretax Income -379.601.000 -460.068.000
17.5%
Net Income Common Stockholders -381.387.000 -453.897.000
16.0%
-- --
--
-- --
--
ende